326 related articles for article (PubMed ID: 25613753)
1. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
[TBL] [Abstract][Full Text] [Related]
3. NCI in vitro and in silico anticancer screen, cell cycle pertubation and apoptosis-inducing potential of new acylated, benzylidene and isopropylidene derivatives of andrographolide.
Wong CC; Sagineedu SR; Sumon SH; Sidik SM; Phillips R; Lajis NH; Stanslas J
Environ Toxicol Pharmacol; 2014 Sep; 38(2):489-501. PubMed ID: 25168151
[TBL] [Abstract][Full Text] [Related]
4. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
5. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
Kim HR; Park CG; Jung JY
Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
[TBL] [Abstract][Full Text] [Related]
6. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway.
Bao Z; Guan S; Cheng C; Wu S; Wong SH; Kemeny DM; Leung BP; Wong WS
Am J Respir Crit Care Med; 2009 Apr; 179(8):657-65. PubMed ID: 19201922
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells.
Hidalgo MA; Romero A; Figueroa J; Cortés P; Concha II; Hancke JL; Burgos RA
Br J Pharmacol; 2005 Mar; 144(5):680-6. PubMed ID: 15678086
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
Imre G; Gekeler V; Leja A; Beckers T; Boehm M
Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide inhibits melanoma tumor growth by inactivating the TLR4/NF-κB signaling pathway.
Zhang QQ; Zhou DL; Ding Y; Liu HY; Lei Y; Fang HY; Gu QL; He XD; Qi CL; Yang Y; Lan T; Li JC; Gong P; Wu XY; Yang X; Li WD; Wang LJ
Melanoma Res; 2014 Dec; 24(6):545-55. PubMed ID: 25244079
[TBL] [Abstract][Full Text] [Related]
10. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.
Lai YH; Yu SL; Chen HY; Wang CC; Chen HW; Chen JJ
Carcinogenesis; 2013 May; 34(5):1069-80. PubMed ID: 23306212
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
[TBL] [Abstract][Full Text] [Related]
12. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.
Lee KY; Park JS; Jee YK; Rosen GD
Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088
[TBL] [Abstract][Full Text] [Related]
13. 2β, 3β, 23-trihydroxy-urs-12-ene-28-olic acid (TUA) isolated from Actinidia chinensis Radix inhibits NCI-H460 cell proliferation by decreasing NF-κB expression.
Cheng QL; Li HL; Huang ZQ; Chen YJ; Liu TS
Chem Biol Interact; 2015 Oct; 240():1-11. PubMed ID: 26134000
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway.
Lee KC; Chang HH; Chung YH; Lee TY
J Ethnopharmacol; 2011 Jun; 135(3):678-84. PubMed ID: 21497192
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.
Dey SK; Bose D; Hazra A; Naskar S; Nandy A; Munda RN; Das S; Chatterjee N; Mondal NB; Banerjee S; Saha KD
PLoS One; 2013; 8(3):e58055. PubMed ID: 23472133
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway.
Gao H; Wang J
Mol Med Rep; 2016 Feb; 13(2):1827-32. PubMed ID: 26707811
[TBL] [Abstract][Full Text] [Related]
17. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression.
Pratheeshkumar P; Sheeja K; Kuttan G
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):143-51. PubMed ID: 21682651
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol loaded gelatin nanoparticles synergistically inhibits cell cycle progression and constitutive NF-kappaB activation, and induces apoptosis in non-small cell lung cancer cells.
Karthikeyan S; Hoti SL; Prasad NR
Biomed Pharmacother; 2015 Mar; 70():274-82. PubMed ID: 25776512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
